Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Keystone Symposium on the Gut Microbiome: The Effector/Regulatory Immune Network
Salvianolic acid B protects the myelin sheath around injured spinal cord axons.
The effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with multiple sclerosis: study protocol for a randomised controlled trial.
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Betaseron (Interferon Beta-1b) for SC Injection
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis.
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro.
The role of pre-morbid intelligence and cognitive reserve in predicting cognitive efficiency in a sample of Italian elderly.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
Interferon-beta1b for the treatment of multiple sclerosis.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Child Neurology Society 41st Annual Meeting
Genetic analysis of aquaporin-4 in neuromyelitis optica.
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
Avonex drug warning letter, severe hypatic injury
Some recent advances in multiple sclerosis.
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
Novantrone
Clinical Reasoning: Left hemiparesis, ataxia, and optic neuritis in a child previously treated for pineoblastoma.
[Information processing speed and influential factors in multiple sclerosis].
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Pages